Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp491 | Other diseases of bone and mineral metabolism | ECTS2013

Cross sectional study of bone mass and 25OH vitamin D levels in erythropoietic protoporphyria

Allo Gonzalo , Martinez-Diaz-Guerra Guillermo , del Carmen Garrido-Astray Maria , de Salamanca Rafael Enriquez , Hawkins Federico

Objectives: Erythropoietic protoporphyria (EPP) is a rare disease with cutaneous photosensitivity, in which patients avoid sun exposure and use sunscreen. Our purpose was to study bone mineral density (BMD), serum 25-OHD levels and other mineral parameters, to evaluate the impact of these measures in the follow-up of EPP patients.Patients and methods: A ten EPP patients (median age 25; range 22–55, four males and six females), were study for clinica...

ba0002oc30 | Chronic diseases | ICCBH2013

Alteration of wnt/β-catenin signaling in HIV-infected youths: a mechanism leading to impaired bone health?

Mora Stefano , Giacomet Vania , Puzzovio Maria , Maruca Katia , Stucchi Sara , Erba Paola , Capelli Silvia , Vigano Alessandra , Zuccotti Gian Vincenzo

Objectives: Impairment of bone mass accrual and alterations of bone metabolism is a common finding in HIV-infected youths. In particular, previous studies demonstrated higher bone formation and bone resorption rates in HIV-infected children and adolescents. Wnt ligands promote bone formation by stimulating osteoblast differentiation and their survival. Recent studies demonstrated that sclerostin (Scl) and dickkopf factor 1 (DKK-1), Wnt antagonists, are important negative regul...

ba0002p27 | (1) | ICCBH2013

Randomized-controlled study in kidney transplanted children: early corticoids withdrawal and effect on bone health recovery

Reyes Maria Loreto , Mericq Veronica , Salas Paulina , Pinto Viola , Cano Francisco , Gonzalez Magdalena , Brown Keenan , Delucchi Angela

Background: Glucocorticoid immune suppression in kidney transplanted children jeopardizes optimal bone health recovery. So far, there are no studies that evaluate the effect of transplant and corticoid in bone parameters separately.Objective: To determine the effect of early corticosteroid withdrawal in bone parameters.Methods: Randomized, controlled study; two groups: corticosteroid withdrawal (at the 6th day post-transplant, then...

ba0002p82 | (1) | ICCBH2013

The influence of sclerostin serum levels on bone mineral density and body composition in patients with Rett syndrome and healthy adolescent girls

Caffarelli Carla , Tanzilli Loredana , Pitinca Maria Dea Tomai , Hayek Joseph , Francolini Valentina , Franci Beatrice , Nuti Ranuccio , Gonnelli Stefano

Objective: Sclerostin, product of the SOST gene, is an important determinant of bone formation and resorption. Rett patients, frequently present marked decreases in bone mineral density (BMD) beyond that expected from disuse atrophy. However, sclerostin has not been yet examined in Rett subjects as a potential mediator of impaired bone metabolism.Methods: This study aimed to investigate whether there is any associations between sclerostin levels, body co...

ba0003cc1 | (1) | ECTS2014

Molecular diagnosis of osteopetrotic patients with atypical presentations using traditional approaches and exome sequencing

Palagano Eleonora , Pangrazio Alessandra , Strina Dario , Puddu Alessandro , Oppo Manuela , Valentini Maria , Vezzoni Paolo , Villa Anna , Sobacchi Cristina

Autosomal Recessive Osteopetrosis (ARO) presents early in life with extreme sclerosis of the skeleton, reduction of bone marrow spaces, hepatosplenomegaly, cranial nerves compression and severe growth failure. ARO is often lethal and at present the only therapy is HSCT, which should be performed as soon as possible in order to obtain a major benefit. ARO is genetically heterogeneous and delays in clinical diagnosis sometimes occur, due to its rareness and to the presence of co...

ba0003pp253 | Osteoporosis: evaluation and imaging | ECTS2014

Bone mass in HIV male patients undergoing antiretroviral therapy

Moro-Alvarez Maria-Jesus , Ryan-Murua Pablo , Troya-Garcia Jesus , Solis-Villa Francisco-Javier , Villa-Azpeitia-Arman Francisco-Javier

Multiple factors of risk have been described to the osteoporosis (OSP) and fractures in people infected by human immunodeficiency virus (HIV). Antiretroviral treatment has changed the vital prognosis of these patients, nevertheless seems that antiretroviral treatments can cause a greater loss of bone mineral density (BMD). Experts support the use of densitometry screening for HIV-infected postmenopausal women and men older than 50 years.Objectives: To ev...

ba0003pp408 | Paediatric bone disease | ECTS2014

Effect of GOS/FOS on calcium and phosphorus absorption and retention during recovering from undernutrition: experimental model in normal growing rats

Bryk Gabriel , Coronel Magali Zeni , Medina Daniela , Mandalunis Patricia , de Portela Maria Luz Pita Martin , Susana Zeni

During early life undernutrition impairs normal weight and height gain that affects bone health. During recovering it is required an extra-amount of Ca to ensure the high demands of bone mineralization. A mixture of galactooligosaccharides (GOS) and fructooligosaccharides (FOS) would be a useful tool to increase mineral intestinal absorption to enhancing the amount of Ca to be retained into bone. Our objective was to evaluate, in an experimental model of protein restriction (P...

ba0004p175 | (1) | ICCBH2015

Effect of baseline vitamin D status on serum 25(OH) D level and body composition in breastfed infants on vitamin D supplementation

Czech-Kowalska Justyna , Jaworski Maciej , Maksym Dorota , Nowakowska-Rysz Monika , Wygledowska Grazyna , Pawlus Beata , Zochowska Anna , Kornacka Maria , Dobrzanska Anna

Objectives: Vitamin D intake at a dose 400 IU/d is recommended for breastfed infants and is considered as sufficient. Vitamin D status is connected with bone mass and fat mass. We aimed to assess, if 400 IU/d has the same efficiency and impact on body composition in infants with different vitamin D status at birth (<20 ng/ml vs ≧20 ng/ml).Methods: 148 breastfed infants were supplemented with 400 IU/d of cholecalciferol up to 6 months of age. S...

ba0005p127 | Cancer and bone: basic, translational and clinical | ECTS2016

LIGHT promotes osteolytic bone metastases in NSCLC patients

Brunetti Giacomina , Belisario Dimas Carolina , Alliod Valentina , Buffoni Lucio , Colucci Silvia , Grano Maria , Ferracini Riccardo , Roato Ilaria

LIGHT is a TNF superfamily member, expressed by activated T cells. It is involved in erosive bone disease, such as rheumatoid arthritis where it stimulates osteoclastogenesis. In multiple myeloma, LIGHT promotes osteolysis by increasing osteoclastogenesis and inhibiting osteoblastogenesis. We investigated whether LIGHT has a role in the osteolytic bone metastatic process induced by non small cell lung cancer (NSCLC), which is a tumor with a marked osteotropism. We analysed by ...